**15. Assessment of the correlation of psychological well-being and QoL in MM**

A cross-sectional survey was conducted aiming to identify the nature and range of needs, as well as levels of quality of life (QoL), of both patients living with myeloma and their partners. Patients and their partners were recruited from 4 hospitals in the United Kingdom at a mean post-diagnosis time of 5 years. A total of 132 patients and 93 of their partners participated. One-quarter of the patients and one-third of the partners reported unmet supportive care needs. About 27.4% of patients reported signs of anxiety and 25.2% reported signs of depression. Almost half the partners (48.8%) reported signs of anxiety and 13.6% exhibited signs of depression. Anxious/depressed patients had more than double the unmet needs than non-anxious/depressed patients (P<0.05). QoL was moderate, with key areas of impairment being physical, emotional, social and cognitive functioning. Patients complained of several symptoms, including tiredness (40.7%), pain (35.9%), insomnia (32.3%), peripheral neuropathies (28.3%) and memory problems (22.3%). About 40.8% were worried about their health in the future [35].
